文献速递肝胆胰外科

「2+3」胰肠吻合在110例胰十二指肠切除术中的应用

[Application of the "2+3" pancreaticojejunostomy in 110 cases of pancreaticoduodenectomy].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2026-01-01

本研究为回顾性病例系列,分析山东大学齐鲁医院同一术者连续完成的110例采用「2+3」胰肠吻合的胰十二指肠切除术患者资料。术后总并发症发生率为20.0%,临床相关胰瘘(CR-POPF)发生率为9.1%,无C级胰瘘、二次手术及围术期死亡。结论认为该吻合方法简单、可靠。

要点

  • 「2+3」胰肠吻合术后CR-POPF发生率为9.1%,无C级胰瘘及围术期死亡。
  • 腹腔镜与开腹组CR-POPF发生率差异无统计学意义(15.9%比4.5%,P=0.086)。
  • 细胰管与粗胰管组CR-POPF发生率差异无统计学意义(12.7%比0,P=0.059)。

核心结论

  • 胰十二指肠切除术中应用「2+3」胰肠吻合法进行胰腺功能重建简单、可靠。

研究设计与样本

  • 回顾性病例系列研究,收集2022年12月至2025年7月山东大学齐鲁医院同一术者连续完成的110例胰十二指肠切除术患者资料。
  • 男性61例,女性49例;年龄(60.9±10.9)岁(范围:21~83岁);术前接受新辅助治疗4例(3.6%)。

主要发现

  • 术后总并发症发生率为20.0%(22/110),临床相关胰瘘(CR-POPF)发生率为9.1%(10/110)。
  • 无C级胰瘘、二次手术及围术期死亡病例;术后住院时间(13.6±4.0)d(范围:7~27 d)。
  • 病理学类型:胰腺癌54例(49.1%),十二指肠(乳头)癌29例(26.4%),胆总管癌10例(9.1%),其他类型肿瘤17例(15.5%)。
  • LPD组与OPD组CR-POPF发生率差异无统计学意义[15.9%(7/44)比4.5%(3/66),P=0.086]。
  • 细胰管组CR-POPF发生率[12.7%(10/79)]与粗胰管组[0(0/31)]差异无统计学意义(P=0.059);软胰腺组与硬胰腺组在手术时间、术中出血量、CR-POPF及术后住院时间方面差异均无统计学意义(P值均>0.05)。

关键数值与推荐

  • 「2」代表采用4-0不可吸收线进行胰腺前后层与肠壁的两个连续缝合,后壁缝合时将胰管后壁与空肠打孔处缝合。
  • 「3」代表采用4-0可吸收线在主胰管6点、12点及3点方位进行胰管对肠管黏膜的3针间断缝合。

临床怎么用

  • 「2+3」胰肠吻合可作为胰十二指肠切除术中胰腺重建的一种简单、可靠术式选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To report the outcomes and evaluate the safety of the "2+3"pancreaticojejunostomy in pancreaticoduodenectomy. Methods: This retrospective case series analyzed clinical data from 110 consecutive pancreaticoduodenectomy patients who underwent "2+3" pancreaticojejunostomy, performed by a single surgeon at Qilu Hospital of Shandong University between December 2022 and July 2025. The cohort comprised 61 males and 49 females, with an age of (60.9±10.9) years (range: 21 to 83 years). Four patients (3.6%) received neoadjuvant therapy preoperatively. The technique features a modified duct-to-mucosa anastomosis: the "2" denotes a double-layer continuous suture of the anterior and posterior pancreatic parenchyma to the jejunum using 4-0 non-absorbable suture, with the posterior line incorporating the dorsal pancreatic duct wall and the jejunotomy; the "3" signifies three interrupted duct-to-mucosa sutures placed at the 6, 12, and 3 o'clock positions using 4-0 absorbable suture. Clinical and pathological data were compared using Student's t-test, Mann-Whitney U test, χ2 test, or Fisher's exact test. Results: The overall postoperative complication rate was 20.0% (22/110), with a 9.1% (10/110) incidence of clinically relevant postoperative pancreatic fistula (CR-POPF). No instances of grade C postoperative pancreatic fistula, reoperations, or perioperative deaths occurred. The postoperative hospital stay was (13.6±4.0) d (range: 7 to 27 d). The pathological types included pancreatic cancer (n=54, 49.1%), duodenal cancer (n=29, 26.4%), distal cholangiocarcinoma (n=10, 9.1%) and other tumors (n=17,15.5%). Patients were categorized based on surgical approach into laparoscopic pancreaticoduodenectomy (LPD) (n=44) and open pancreaticoduodenectomy (OPD) (n=66) groups. There was no statistically significant difference in the CR-POPF rate between the LPD group and the OPD group (15.9% (7/44) vs. 4.5% (3/66), P=0.086). Based on pancreatic duct diameter, patients were divided into a non-dilated duct group (n=79) and a dilated duct group (n=31). Compared with the dilated duct group(0 (0/31)), the CR-POPF incidence in the non-dilated duct group(12.7% (10/79)) showed no statistically significant difference (P=0.059). There were no statistically significant differences in operative time, intraoperative blood loss, CR-POPF rate, or postoperative hospital stay between patients with soft pancreas (n=68) and hard pancreas (n=42) (all P>0.05). Conclusion: The "2+3" pancreaticojejunostomy technique for pancreatic reconstruction during pancreaticoduodenectomy is effective and reliable. 目的: 探讨“2+3”胰肠吻合法在胰十二指肠切除术中的应用效果。 方法: 本研究为回顾性病例系列研究。收集2022年12月至2025年7月山东大学齐鲁医院胰腺外科由同一术者连续完成的110例胰十二指肠切除术(术中采用“2+3”胰肠吻合)的患者资料。男性61例,女性49例;年龄(60.9±10.9)岁(范围:21~83岁)。术前接受新辅助治疗4例(3.6%)。“2+3”胰肠吻合法为改良的导管对黏膜吻合方法,“2”代表采用4-0不可吸收线进行胰腺前后层与肠壁的两个连续缝合(后壁缝合时将胰管后壁与空肠打孔处缝合),“3”代表采用4-0可吸收线在主胰管6点、12点及3点方位进行胰管对肠管黏膜的3针间断缝合。组间患者临床和病理学资料的比较使用Student′s t检验、Mann-Whitney U检验、χ2检验或Fisher确切概率法。 结果: 术后总并发症发生率为20.0%(22/110),临床相关胰瘘(CR-POPF)发生率为9.1%(10/110),无C级胰瘘、二次手术及围术期死亡病例。术后住院时间(13.6±4.0)d(范围:7~27 d)。病理学类型:胰腺癌54例(49.1%),十二指肠(乳头)癌29例(26.4%),胆总管癌10例(9.1%),其他类型肿瘤17例(15.5%)。根据手术方式分为腹腔镜胰十二指肠切除术(LPD)组(44例)和开腹胰十二指肠切除术(OPD)组(66例)。LPD组与OPD组CR-POPF发生率的差异无统计学意义[15.9%(7/44)比4.5%(3/66),P=0.086]。根据胰管直径分为细胰管组(79例)和粗胰管组(31例)。细胰管组CR-POPF发生率[12.7%(10/79)]与粗胰管组[0(0/31)]相比,差异亦无统计学意义(P=0.059)。根据胰腺质地分为软胰腺组(68例)和硬胰腺组(42例),两组患者在手术时间、术中出血量、CR-POPF及术后住院时间等方面的差异均无统计学意义(P值均>0.05)。 结论: 胰十二指肠切除术中应用“2+3”胰肠吻合法进行胰腺功能重建简单、可靠。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Guo SL, Chen SH, Liu H, et al. [Application of the "2+3" pancreaticojejunostomy in 110 cases of pancreaticoduodenectomy]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 42350893. doi:10.3760/cma.j.cn112139-20251116-00534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。